✦ LIBER ✦

Boceprevir for chronic HCV genotype 1 infection in patients with prior treatment failure to peginterferon/ribavirin, including prior null response

✍ Scribed by Vierling, John M.; Davis, Mitchell; Flamm, Steven; Gordon, Stuart C.; Lawitz, Eric; Yoshida, Eric M.; Galati, Joseph; Luketic, Velimir; McCone, Jonathan; Jacobson, Ira; Marcellin, Patrick; Muir, Andrew J.; Poordad, Fred; Pedicone, Lisa D.; Albrecht, Janice; Brass, Clifford; Howe, Anita Y.M.; Colvard, Lynn Y.; Helmond, Frans A.; Deng, Weiping; Treitel, Michelle; Wahl, Janice; Bronowicki, Jean-Pierre

Book ID: 121674987
Publisher: Elsevier Science
Year: 2014
Tongue: English
Weight: 840 KB
Volume: 60
Category: Article
ISSN: 0168-8278
DOI: 10.1016/j.jhep.2013.12.013

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Projecting the Long-Term Clinical Impact

Projecting the Long-Term Clinical Impact of Boceprevir in Patients With Chronic Hepatitis C Genotype-1 Who Failed Prior Treatment With Peginterferon/Ribavirin

✍ Chhatwal, Jagpreet ;Ferrante, Shannon A. ;Dasbach, Erik J. ;El Khoury, Antoine ; 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 469 KB

Response-Guided Therapy With Boceprevir

Response-Guided Therapy With Boceprevir Plus Peginterferon Alfa-2B/Ribavirin Reduces Treatment Duration in NaïVE and Peginterferon Alfa-2B/Ribavirin Previous-Treatment-Failure Patients With HCV Genotype 1

✍ Manns, Michael P. ;Poordad, Fred ;Bacon, Bruce R. ;Bruno, Savino ;Esteban, Rafae 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 258 KB

409 PROJECTING THE LONG-TERM CLINICAL IM

409 PROJECTING THE LONG-TERM CLINICAL IMPACT OF BOCEPREVIR IN PATIENTS WITH CHRONIC HEPATITIS C GENOTYPE-1 WHO FAILED PRIOR TREATMENT WITH PEGINTERFERON/RIBAVIRIN

✍ J. Chhatwal; S.A. Ferrante; E.J. Dasbach; A. El Khoury; M. Burroughs; B. Bacon; 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 40 KB

Telaprevir with peginterferon and ribavi

Telaprevir with peginterferon and ribavirin for treatment-naive patients chronically infected with HCV of genotype 1 in Japan

✍ Hiromitsu Kumada; Joji Toyota; Takeshi Okanoue; Kazuaki Chayama; Hirohito Tsubou 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 792 KB

448 RESPONSE-GUIDED THERAPY WITH BOCEPRE

448 RESPONSE-GUIDED THERAPY WITH BOCEPREVIR PLUS PEGINTERFERON ALFA-2B/RIBAVIRIN REDUCES DURATION IN NAIVE AND PEGINTERFERON ALFA-2B/RIBAVIRIN PREVIOUS-TREATMENT-FAILURE PATIENTS WITH HCV GENOTYPE 1

✍ M.P. Manns; F. Poordad; B.R. Bacon; S. Bruno; R. Esteban; M. Silva; M. Buti; M. 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 114 KB

Telaprevir-Based Regimen in Genotype 1 H

Telaprevir-Based Regimen in Genotype 1 Hepatitis C Virus-Infected Patients With Prior Null Response, Partial Response or Relapse to Peginterferon/Ribavirin: REALIZE Trial Final Results

✍ Pockros, Paul ;Zeuzem, Stefan ;Lawitz, Eric J. ;Younossi, Zobair M. ;Andreone, P 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 552 KB